Matthew T Plavan - Net Worth and Insider Trading

Matthew T Plavan Net Worth

The estimated net worth of Matthew T Plavan is at least $29,445 dollars as of 2024-04-25. Matthew T Plavan is the CEO of Arcadia Biosciences Inc and owns about 14,285 shares of Arcadia Biosciences Inc (RKDA) stock worth over $29,427. Matthew T Plavan is also the Former CEO of ThermoGenesis Holdings Inc and owns about 27 shares of ThermoGenesis Holdings Inc (THMO) stock worth over $18. Details can be seen in Matthew T Plavan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matthew T Plavan has not made any transactions after 2020-08-03 and currently still holds the listed stock(s).

Transaction Summary of Matthew T Plavan

To

Matthew T Plavan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew T Plavan owns 3 companies in total, including Arcadia Biosciences Inc (RKDA) , ThermoGenesis Holdings Inc (THMO) , and Origin Materials Inc (ORGN) .

Click here to see the complete history of Matthew T Plavan’s form 4 insider trades.

Insider Ownership Summary of Matthew T Plavan

Ticker Comapny Transaction Date Type of Owner
RKDA Arcadia Biosciences Inc 2020-08-03 Chief Financial Officer
THMO ThermoGenesis Holdings Inc 2015-09-02 Chief Financial Officer
ORGN Origin Materials Inc 2023-10-30 Chief Financial Officer

Matthew T Plavan Latest Holdings Summary

Matthew T Plavan currently owns a total of 2 stocks. Among these stocks, Matthew T Plavan owns 14,285 shares of Arcadia Biosciences Inc (RKDA) as of August 3, 2020, with a value of $29,427 and a weighting of 99.94%. Matthew T Plavan also owns 27 shares of ThermoGenesis Holdings Inc (THMO) as of September 2, 2015, with a value of $18 and a weighting of 0.06%.

Latest Holdings of Matthew T Plavan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RKDA Arcadia Biosciences Inc 2020-08-03 14,285 2.06 29,427
THMO ThermoGenesis Holdings Inc 2015-09-02 27 0.65 18

Holding Weightings of Matthew T Plavan


Matthew T Plavan Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthew T Plavan has made a total of 6 transactions in Arcadia Biosciences Inc (RKDA) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Arcadia Biosciences Inc is the acquisition of 585 shares on August 3, 2020, which cost Matthew T Plavan around $1,849.

According to the SEC Form 4 filings, Matthew T Plavan has made a total of 0 transactions in ThermoGenesis Holdings Inc (THMO) over the past 5 years. The most-recent trade in ThermoGenesis Holdings Inc is the sale of 2 shares on September 2, 2015, which brought Matthew T Plavan around $11,744.

Insider Trading History of Matthew T Plavan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthew T Plavan Trading Performance

GuruFocus tracks the stock performance after each of Matthew T Plavan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew T Plavan is -9.13%. GuruFocus also compares Matthew T Plavan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew T Plavan within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Matthew T Plavan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Matthew T Plavan

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -13.7 -9.13 -31.87 -44.69 -43.89 -57.09
Relative Return to S&P 500(%) -13.91 -12.57 -29.13 -62.94 -64.2 -66.76

Matthew T Plavan Ownership Network

Ownership Network List of Matthew T Plavan

No Data

Ownership Network Relation of Matthew T Plavan


Matthew T Plavan Owned Company Details

What does Arcadia Biosciences Inc do?

Who are the key executives at Arcadia Biosciences Inc?

Matthew T Plavan is the Chief Financial Officer of Arcadia Biosciences Inc. Other key executives at Arcadia Biosciences Inc include Chief Financial Officer Thomas J. Schaefer , Chief Executive Officer Stanley Jr Jacot , and Chief Financial Officer Pamela Haley .

Arcadia Biosciences Inc (RKDA) Insider Trades Summary

Over the past 18 months, Matthew T Plavan made no insider transaction in Arcadia Biosciences Inc (RKDA). Other recent insider transactions involving Arcadia Biosciences Inc (RKDA) include a net purchase of 2,049 shares made by Thomas J. Schaefer , and a net purchase of 5,000 shares made by Stanley Jr Jacot .

In summary, during the past 3 months, insiders sold 0 shares of Arcadia Biosciences Inc (RKDA) in total and bought 700 shares, with a net purchase of 700 shares. During the past 18 months, 0 shares of Arcadia Biosciences Inc (RKDA) were sold and 7,049 shares were bought by its insiders, resulting in a net purchase of 7,049 shares.

Arcadia Biosciences Inc (RKDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcadia Biosciences Inc Insider Transactions

No Available Data

Matthew T Plavan Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew T Plavan. You might contact Matthew T Plavan via mailing address: C/o Thermogenesis Corp., 2711 Citrus Road, Rancho Cordova Ca 95742.

Discussions on Matthew T Plavan

No discussions yet.